GlassScriptPhysician profile
Yolanda Edith Dingess
NPI 1124061429
$453.57
in general payments reported to CMS, 2019-2025
18 companies · $96.56 in 2025
The $96.56 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $13.13 · 2021: $43.43 · 2022: $84.82 · 2023: $31.63 · 2024: $49.14 · 2025: $96.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $83.28 | 2019-2025 | Bexsero, Penmenvy |
| Amgen INC. | $58.95 | 2022-2024 | Tezspire |
| Sanofi Pasteur INC. | $37.55 | 2021-2023 | |
| Seqirus USA INC | $32.65 | 2025 | Flucelvax |
| Shire North American Group INC | $29.70 | 2019 | |
| Phadia US INC. | $26.28 | 2021-2023 | Immunocap |
| Merck Sharp & Dohme LLC | $26.03 | 2025 | Gardasil 9, Enflonsia |
| Cranial Technologies, INC | $25.05 | 2019-2020 | |
| Alk-Abello, INC | $16.33 | 2025 | Neffy |
| Kaleo, INC. | $14.91 | 2022 | |
| Sobi, INC | $14.47 | 2019 | |
| Aimmune Therapeutics, INC. | $14.17 | 2022 | |
| Tris Pharma INC | $13.78 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.68 | 2022 | |
| Mission Pharmacal Company | $13.26 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11.23 | 2021 | |
| Ironshore Pharmaceuticals INC. | $11.23 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yolanda Dingess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.